Patents by Inventor J. Allan Waitz

J. Allan Waitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wearable drug delivery device for disease management and system therefor with artificial intelligence
    Patent number: 11969577
    Abstract: Apparatus(es)/method(s) relating generally to remotely administering a medication is/are disclosed. In one such method, a drug delivery device is obtained. The drug delivery device has: at least one reservoir in fluid communication with a needle; at least one actuator to drive a fluid within a respective at least one reservoir to the needle; a microcontroller to control operation of the at least one actuator; and a dosage control loop configured for communication with the microcontroller and a hemoglobin sensor. A dosage provided by the drug delivery device is automatically adjusted responsive to hemoglobin count sensed by the hemoglobin sensor for transdermal administration of medication for management of chronic kidney disease.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: April 30, 2024
    Inventors: Mandeep Sahani, An-Dien Nguyen, J. Allan Waitz, Linh C. Nguyen
  • ATCC 53620 production of a triacetylenic dioxolone with Microbispora sp. SCC 1438
    Patent number: 5143832
    Abstract: The novel triacetylenic dioxolone antifungal compound of this invention is isolated from the EV-22 complex of this invention which is elaborated by the microorganism Microbispora sp. SCC 1438, ATCC 53620.
    Type: Grant
    Filed: July 3, 1990
    Date of Patent: September 1, 1992
    Assignee: Schering Corporation
    Inventors: Mahesh Patel, Ann C. Horan, Joseph A. Marquez, J. Allan Waitz
  • Antifungal triacetylenic dioxolone from Microbispora sp. SCC 1438, ATCC 53620
    Patent number: 4956383
    Abstract: The novel triacetylenic dioxolone antifungal compound of this invention is isolated from the EV-22 complex of this invention which is elaborated by the microorganism Microbispora sp. SCC 1438, ATCC 53620.
    Type: Grant
    Filed: August 25, 1987
    Date of Patent: September 11, 1990
    Assignee: Schering Corporation
    Inventors: Mahesh G. Patel, Ann C. Horan, Joseph A. Marquez, J. Allan Waitz
  • Process of producing antibiotic AR-5 complex
    Patent number: 4367287
    Abstract: The Antiboitic AR-5 complex is elaborated by a novel species of the Micromonospora; namely, Micromonospora polytrota. The microorganism also elaborates a number of minor components including the gentamicin complex and a complex of anthroquinone antibiotics.
    Type: Grant
    Filed: October 9, 1981
    Date of Patent: January 4, 1983
    Assignee: Schering Corporation
    Inventors: J. Allan Waitz, Walter Reiblein, Imbi Truumees
  • Macrolide antibiotic complex
    Patent number: 4349665
    Abstract: The AR-5-3 Complex consisting of four macrolide antibiotics is elaborated by a mutant strain of Micromonospora polytrota. The antibiotics exhibit substantial activity against gram positive bacteria in vitro and in vivo.
    Type: Grant
    Filed: June 27, 1980
    Date of Patent: September 14, 1982
    Assignee: Schering Corporation
    Inventors: Bong K. Lee, Joseph A. Marquez, J. Allan Waitz
  • Antibiotic AR-5 complex, antibiotics coproduced therewith and derivatives thereof
    Patent number: 4307085
    Abstract: The Antibiotic AR-5 complex is elaborated by a novel species of the Micromonospora; namely, Micromonospora polytrota. The microorganism also elaborates a number of minor components including the gentamicin complex and a complex of gentamicin antibiotics.
    Type: Grant
    Filed: November 9, 1979
    Date of Patent: December 22, 1981
    Assignee: Schering Corporation
    Inventors: J. Allan Waitz, Walter Reiblein, Imbi Truumees